Market Cap
$74.13 Billion
USD as of Jan. 1, 2023
Company | Market Cap (USD) |
---|---|
![]() |
$304.61 B |
![]() |
$93.24 B |
![]() |
$79.53 B |
Marinomed Biotech AG | $76.72 B |
![]() |
$68.42 B |
Company | Market Cap (USD) |
---|---|
![]() |
$495.37 B |
![]() |
$461.85 B |
![]() |
$347.61 B |
![]() |
$304.61 B |
![]() |
$287.63 B |
Vertex Pharmaceuticals Incorporated is a pharmaceuticals and biotherapeutics company. It notably produces drugs and genetic therapies for cystic fibrosis and other skin conditions, such as pain, sickle cell disease, beta-thalassemia, hormonal deficiencies, kidney diseases, Duchenne muscular dystrophy, and diabetes.
Vertex Pharmaceuticals Incorporated has the following listings and related stock indices.
Stock: NASDAQ: VRTX
Stock: FSX: VX1
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.